RESUMEN
BACKGROUND: The incidence of bloodstream infection (BSI) varies according to the transplanted organ. Mortality can be as high as 24%, with a significant impact on graft survival. Transplantation is a risk factor for multidrug-resistant (MDR) organisms, but comparison with a non-transplanted population in a single large cohort has not been described. METHODS: This is a prospective nationwide study (16 centers) reporting data on 2364 monomicrobial nosocomial BSIs, comparing 83 episodes in solid organ transplant patients with 2447 BSIs occurring in the general hospital population. RESULTS: The prevalence of groups of infecting organisms (gram-positive, gram-negative, and fungi) was similar between transplant patients and the general population and a similar crude mortality rate was observed (34.9% in transplant vs. 43.3% in non-transplant patients). Staphylococcus aureus was the single most frequently isolated organism in both groups, and Acinetobacter species was more frequently isolated in the general population. Regarding MDR organisms, Klebsiella species, and Enterobacter species resistant to cefepime, as well as Acinetobacter species resistant to meropenem, were significantly more frequent in transplant patients. CONCLUSION: Antimicrobial resistance is higher, particularly among gram-negative bacteria in the transplant population, although the overall mortality rate between transplant and non-transplant patients with nosocomial BSI is similar.
Asunto(s)
Bacteriemia/epidemiología , Candidemia/epidemiología , Infección Hospitalaria/epidemiología , Receptores de Trasplantes/estadística & datos numéricos , Infecciones por Acinetobacter/epidemiología , Infecciones por Acinetobacter/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Bacteriemia/microbiología , Brasil/epidemiología , Candidemia/microbiología , Niño , Preescolar , Infección Hospitalaria/microbiología , Farmacorresistencia Bacteriana , Infecciones por Escherichia coli/epidemiología , Infecciones por Escherichia coli/microbiología , Femenino , Fungemia/epidemiología , Fungemia/microbiología , Humanos , Lactante , Recién Nacido , Infecciones por Klebsiella/epidemiología , Infecciones por Klebsiella/microbiología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Infecciones por Pseudomonas/epidemiología , Infecciones por Pseudomonas/microbiología , Infecciones Estafilocócicas/epidemiología , Infecciones Estafilocócicas/microbiología , Adulto JovenRESUMEN
The impact of surgical site infections (SSIs) on graft function in kidney transplant recipients is controversial. We conducted a matched case-control study (1:1 ratio) between April 2001 and December 2004 in a Brazilian cohort of kidney transplant recipients. The epidemiological and clinical characteristics of SSIs were described based on chart review. The impact on graft function was assessed by comparing serum creatinine measurements and creatinine clearance up to 18 months after transplantation with analysis of variance model. Among 1939 kidney transplants, 120 patients with 145 SSIs were enrolled. Most wound infections were superficial (73.1%). The mortality rate was 0.8%. No impact on graft function was detected. In conclusion, accurate identification of SSIs may have resulted in shorter hospitalization periods, but they had no impact on graft function up to 18 months post transplantation.
Asunto(s)
Trasplante de Riñón/efectos adversos , Riñón/fisiopatología , Infección de la Herida Quirúrgica/fisiopatología , Adolescente , Adulto , Anciano , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Infección de la Herida Quirúrgica/mortalidad , Trasplante HomólogoRESUMEN
Antimicrobial- and antiseptic-impregnated catheters are strategies recommended to prevent central venous catheter (CVC) colonisation. Few data regarding chlorhexidine/silver sulfadiazine-impregnated catheters in intensive care unit (ICU) patients have been reported. We performed a prospective, randomised study comparing the colonisation rates of chlorhexidine/silver sulfadiazine-impregnated CVCs (group 1) against standard CVCs (group 2). In order to assess catheter colonisation rates, a 4cm segment from the tips of aseptically removed catheters was cultured by the roll-plate method. In all, 109 patients were enrolled with successful catheter insertion, 51 of them in group 1 and 58 in group 2. There were no statistically significant differences between the two groups with regards to age, Sequential Organ Failure Assessment (SOFA) score, ICU admission diagnosis, infection risk, catheter insertion sites or catheter length of stay. The colonisation rates were 29.4% (15 catheters) for group 1 and 34.5% (20 catheters) for group 2 (P=0.50). Double-lumen CVCs impregnated with chlorhexidine and silver sulfadiazine were not effective in reducing the incidence of catheter colonisation in ICU patients.
Asunto(s)
Antibacterianos/farmacología , Infecciones Relacionadas con Catéteres/prevención & control , Cateterismo , Clorhexidina/farmacología , Equipos y Suministros/microbiología , Sulfadiazina de Plata/farmacología , Anciano , Anciano de 80 o más Años , Bacterias/aislamiento & purificación , Femenino , Hongos/aislamiento & purificación , Humanos , Unidades de Cuidados Intensivos , Masculino , Persona de Mediana Edad , Estudios ProspectivosRESUMEN
BACKGROUND: Antilymphocyte antibodies (ALA) use is related to disseminated cytomegalovirus (CMV) disease after kidney transplantation. Strict surveillance of CMV infection, preemptive antiviral treatment or concomitant ganciclovir and ALA use are proposed as an attempt to prevent related clinical complications. Our objective was to describe the pattern of CMV infection, based on sequential antigenemia detection, after ALA treatment. PATIENTS AND METHODS: Thirty renal transplant patients were prospectively screened for CMV infection after ALA treatment. CMV antigenemia (pp65 antigen detection) was monitored twice a week in the first month and weekly until 60 days after the beginning of ALA therapy. Any positive value of antigenemia was considered CMV infection. RESULTS: Twenty-eight (93.3%) patients were CMV positive (IgG) before transplantation. The mean duration of ALA treatment was 12.1+/-2.4 days. Positive antigenemia was detected in 24 (80%) patients, a mean of 52.5+/-15 days after transplant and 44.7+/-14 days after the beginning of ALA treatment. The median antigenemia count was 7 positive cells/300,000 neutrophils (range: 1-227). Antigenemia preceded clinical symptoms by 5.8 days (0-28 days). Eighteen (75%) of 24 positive patients received ganciclovir treatment: 8 patients (26.7%) for viral syndrome, 2 patients (33.3%) for invasive disease, and 8 patients (26.7%) as part of preemptive therapy, asymptomatic with high antigenemia values. Six pp65-positive patients with low counts were followed up until a negative result and remained asymptomatic without any specific treatment. CONCLUSION: CMV infection was frequent after ALA treatment in this group and generally occurred late after completion of treatment. Antigenemia was a reliable tool to guide preemptive treatment in these patients, and such strategy is an alternative option compared to the prophylactic use of ganciclovir with ALA treatment.
Asunto(s)
Suero Antilinfocítico/administración & dosificación , Infecciones por Citomegalovirus/diagnóstico , Inmunosupresores/administración & dosificación , Trasplante de Riñón/efectos adversos , Fosfoproteínas/sangre , Proteínas de la Matriz Viral/sangre , Adulto , Suero Antilinfocítico/uso terapéutico , Citomegalovirus/aislamiento & purificación , Infecciones por Citomegalovirus/virología , Femenino , Humanos , Inmunosupresores/uso terapéutico , Masculino , Persona de Mediana Edad , Factores de TiempoRESUMEN
Apesar da utilizaçäo de esquemas mais racionais de imunodepressäo, as infecçöes continuam respondendo por grande parte da morbi-mortalidade após transplantes de órgäos. Em transplante cardíaco, as infecçöes ocorrem em 31 por cento a 90 por cento dos pacientes, dependendo dos critérios diagnósticos adotados e das infeçöes consideradas. As infecçöes respondem por 17 por cento a 40 por cento das causas de óbito e säo a causa mais frequente de óbito entre o 15 dia e o terceiro mês pós-transplante. As btérias, como grupo, säo os agentes mais importantes e as pneumonias bacterianas de origem hospitalar, as infecçöes mais comuns. Pneumonias extra-hospitalares säo as principais causas de infecçöes mais comuns. Pneumonias extra-hospitalares säo as principais causas de infecçäo e doença após o transplante (após o sexto mês), havendo maior sucetibilidade a infecçöes penuemocócicas. O citomegalovírus isoladamente é o agente etiológico mais frequente de infecçäo e doença após o transplante; além de doença clíia de manifestaçöes variadas, pode estar relacionado a episódios de rejeiçäo causadas por fungos e protozoários, embora menos frequentes, estäo associadas a altíssima letalidade, principalmente as infecçöes disseminadas por Candida sp, Aspergillus sp e Toxoplasma gondii. Neste artigo säo descritos os aspectos gerais dos processos infecciosos após transplante cardíaco, bem como particularidades dos principais agentes envolvidos.